Investors - Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

Our websites

 

Middle area:

Investor Relations Awards

The Investor Relations awards received these last years reflect the considerable efforts done by management and the Investor Relations team to actively engage with the financial community. “We thank investors and analysts for their votes”, declared Christopher A. Viehbacher, Sanofi CEO. “Our awards recognize the high-quality dialogue between the company and the financial community and underscore Sanofi’s commitment to excellence in Investor Relations”.

 

Awards 2013

 

EXTEL Survey 2013

  • 1st company in the European pharmaceutical sector
  • 1st company in France
  • 3rd pan-European quoted company across all sectors

In June 2013, Sanofi was voted first for Investor Relations in the Pharmaceutical & Biotechnology sector in Europe and first company in France in the 2013 EXTEL Survey. Sanofi ranks first for the fourth year in a row in these two categories. Sanofi was also voted third company in Pan-Europe. For the fourth year in a row, Sanofi consistently ranks in the Top 5 in Europe, across all sectors.

 

IR Magazine Europe Awards 2013

  • Best Investor Relations by a French company
 

Global Top 50 Awards

  • Sanofi ranks #11 among all companies worldwide for IR

The Global Top 50 Awards were announced in November 2013 at the Global IR Forum presented by IR Magazine and NIRI.

 

Awards 2012

 

EXTEL Survey 2012

  • 1st pan-European quoted company across all sectors
  • 1st company in the European pharmaceutical sector
  • 1st company in France 

On June 12, 2012, Sanofi was granted the award for “Leading Pan-European Quoted Company for Investor Relations” in the EXTEL survey 2012. For the third year in a row, Sanofi’s Investor Relations was ranked first in France as well as in the European pharmaceutical sector.

 

AGEFI Awards - “Grands Prix de l’AGEFI de l’Analyse Financière” - 2012

  • Best French company for Investor Relations

Sanofi was granted, on June 28, 2012, “Best French company for Investor Relations” in the survey lead by AGEFI.

  • Palmarès des Grands prix de l'analyse financière”. AGEFI Hebdo; 28 juin-4 juillet 2012; N°331; p. 30-31 (in French).
  • Les lauréats 2012 des Grands prix de l'analyse financière”. AGEFI Hebdo; 5-11 juillet 2012; N°332; p. 52-53 (in French).
 

FT Bowen Craggs Index 2012

  • 2nd best Investor Relations website

In April 2012, and for the second year in a row, Sanofi’s Investor Relations section of its website ranked second in FT Bowen Craggs Index. The Index covers 81 of the world’s giant corporations.

 

Awards 2011

 

EXTEL Survey 2011

  • 1st company in the European pharmaceutical sector
  • 1st company among CAC 40
  • 2nd pan-European quoted company across all sectors

The results of the pan-European EXTEL 2011 study once again recognized the high-quality dialogue between the company and the financial community. For the second year in a row, Sanofi’s Investor Relations was ranked first in France as well as in the European pharmaceutical sector.

 

AGEFI Awards - “Grands Prix de l’AGEFI de l’Analyse Financière” - 2011

  • Best Investor Relations for a French issuer
 

IR Magazine Europe Awards 2011

  • Best Investor Relations by a French company
 

IR Awards from World Finance 2011

  • Best Investor Relations website in France

On July 6, 2011, in the more specific field of online financial communications, the IR Awards 2011 organized by the financial magazine World Finance announced Sanofi as the winner of the Best IR website in France.

 

IR Forum 2011

  • Best Investor Relations across all categories

On November 24, 2011, the 4th edition of the French Investor Relations Forum awarded Sébastien Martel, Vice-President, Investor Relations, the prize for “Best Investor Relations in France across all categories”.

 

FT Bowen Craggs Index 2011

  • 2nd best Investor Relations website

In May 2011, the study of the research and consultancy group Bowen Craggs & Co ranked Sanofi’s IR website ahead of all European pharmaceutical companies and any other CAC 40 companies. It awarded the prize of 2nd best website for his IR pages among the 100 biggest companies in the world.

 

Awards 2010

 

EXTEL Survey 2010

  • 1st Investor Relations among French listed companies (CAC40)
  • 1st Investor Relations among European Pharmaceutical companies

For the first time, Sanofi entered the Top 10 European ranking at the fifth place (all sectors taken together). Sanofi was the one and only pharmaceutical company present in the Top 25 and the first of only 3 companies listed on the French Stock exchange.

 

IR Forum 2010

  • Best Investor Relations by a CEO

Sanofi was recognized by the IR Forum for the first year. In the 2010 edition, Christopher A. Viehbacher received the prize for “Best Investor Relations by a CEO” in France.

 

Awards 2009

EXTEL Survey 2009

For the first time in 2009, Sanofi entered the Top 50 European ranking for all sectors in 31st position.

 

Right area:

Stock Market

IR mobile application

Download IR Application

SANOFI IR is available on iPhone, iPad and Android!

 

Your services

© Sanofi 2004-2014 - All rights reserved - Update: January 20, 2014